Issue: July 2012
July 01, 2012
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
ADVANCE III
Issue: July 2012
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Primary endpoint was to demonstrate a 20% reduction of ventricular therapies delivered for treating spontaneous arrhythmia episodes with a fast cycle length.